Segment disclosures

Company overview

Iambic Therapeutics, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 4 retained observations 2 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Single Reporting Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=iam:SingleReportingSegmentMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-3011351000 USD20261119Open filing evidence
2026-01-01 – 2026-09-3024105000 USD20261119Open filing evidence
2025-07-01 – 2025-09-304692000 USD20261119Open filing evidence
2025-01-01 – 2025-09-308621000 USD20261119Open filing evidence